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Purpose: To determine the association between the serum concentration of triiodothyronine (T3) with
components of metabolic syndrome (MetS), cardiovascular risk (CVR), and diet in euthyroid post-menopausal
women without and with MetS.
Methods: A cross-sectional study was performed in 120 voluntary women of an indigenous population from
Tlaxcala-México. Euthyroid status was assessed measuring the serum concentration of thyrotropin (TSH) and thyroid
hormones, while that of estradiol was measured to confirm the postmenopausal condition. MetS was diagnosed using the
American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (AHA/NHLBI) criterion. Estimation
of CVR was calculated based on the Framingham scale. Diet components were evaluated based on survey applications.
Correlations, logistic regression analyses, ANOVA or Kruskall-Wallis, and chi-square tests were used to determine significant
differences (P≤ 0.05) between women without MetS and women with MetS having different serum concentrations of T3.
Results: Triiodothyronine was positively correlated with insulin but negatively correlated with glucose, high-density
lipoprotein cholesterol (HDL-C), and CVR. Compared to women without MetS, women with MetS and low-normal T3
concentration showed a high risk for hyperglycemia and moderate/high risk for CVR. In contrast, a high-normal T3
concentration increased the risk to have a big waist circumference, a high concentration of HDL-C, and insulin resistance.
Diet analysis showed a high grade of malnutrition in women from all groups. The intake of calories was positively affected
by the T3 concentration, albeit it did not affect the extent of malnutrition.
Conclusions: In contrast to concentrations of TSH, total thyroxin (T4), and free T4, the concentration of serum T3 was
strongly correlated with cardio-metabolic variables in euthyroid postmenopausal women. In comparison to women
without MetS, a high-normal serum concentration of T3 in women with MetS is positively associated with reduced
glycaemia and CVR but negatively related to body mass index (BMI), insulin, insulin resistance, and HDL-C. Although
the analyzed population had a nutritional deficiency, both calories and iron intake were positively affected by the
T3 concentration. Our results suggest the necessity of health programs monitoring T3 in old people in order to
treat hyperglycemia, cardio-metabolic components, and the ageing anorexia.
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Hypothyroidism (overt or subclinical) has been associated
with components of metabolic syndrome (MetS) and car-
diovascular diseases (Ichiki 2010). Even in a euthyroid sta-
tus, a positive correlation between the concentration of free
thyroxin (T4) and thyrotropin (TSH) and cardio-metabolic
variables has been reported (Roos et al. 2007; Park et al.
2009; Takamura et al. 2009; Chin et al. 2014). Although
scarcely studied, the influence of triiodothyronine (T3; free
or total) seems to be negative for obesity, insulin concentra-
tion, insulin resistance, systolic and diastolic blood pres-
sure, and dyslipidemias (De Pergola et al. 2010; Chin et al.
2014; Roef et al. 2014), but is favored by hyperglycemia
(De Pergola et al. 2010).
Some studies have found that the relationship between
thyroid hormones and cardio-metabolic variables may
be intensified in patients with diabetes, obesity, or MetS
(De Pergola et al. 2010; Lambadiari et al. 2011; Taneichi
et al. 2011; Tarcin et al. 2012; Topsakal et al. 2012), sug-
gesting that the onset of these pathologies could affect the
thyroid function. In agreement, it has been suggested
that obese people with a normal thyroid gland may have
a hyperactivated hypothalamic-pituitary-thyroid axis,
increasing the concentration of TSH and thyroid hor-
mones (Laurberg et al. 2012). Other studies have reported
that the presence of MetS components in euthyroid sub-
jects can vary between the lowest and highest serum con-
centrations of TSH or T4. Thus, the prevalence of MetS
increases as the normal-TSH quartile (Park et al. 2009),
the risk for insulin resistance increases in the lowest-
normal concentration of freeT4 (Roos et al. 2007), and the
prevalence of MetS is low at higher free T4 quintiles (Kim
et al. 2009). Remarkably, an exploration of cardio-metabolic
variables according to normal-T3 concentration has not
been done.
Although different factors could influence on the rela-
tionship between thyroid hormones and cardio-metabolic
variables, composition of diet, which is clearly related to
MetS and cardiovascular diseases (Skilton et al. 2008;
Motamed et al. 2013), remains unexplored. Despite type
of diet and intestinal absorption of thyroid hormones in
dogs seem to be uncorrelated (Iemura et al. 2013), the
concentration of thyroid hormones is indeed affected by
the type of diet (Rabolli and Martin 1977; Serog et al.
1982; Hennemann et al. 1988; Roti et al. 2000). Another
important factor to be considered for this relationship is
the age. Ageing increases the onset of cardio-metabolic
pathologies (Regitz-Zagrosek et al. 2006; Heidari et al.
2010) in response to a nutritional deficiency induced by
the ageing anorexia and the loss of dentition (Kmieć
et al. 2013; Soenen and Chapman 2013). Ageing also
promotes a natural decrease in the pituitary TSH secre-
tion and deiodination of T4, while increases the occur-
rence of anti-thyroglobulin and anti-thyroperoxidaseantibodies (Benseñor et al. 2012). Both quality of diet
and ageing could affect the association between thyroid
hormones and cardio-metabolic variables. In old sub-
jects, but not in young ones, retinol blood concentra-
tion is negatively associated with free T4 and TSH,
while zinc is positively associated with free T3 (Ravaglia
et al. 2000). Furthermore, the concentration of gastro-
intestinal molecules involved in the appetite regulation
and the ageing anorexia is affected by the thyroid status
(i.e. ghrelin and obestatin) (Emami et al. 2014).
The aim of the present study is therefore to determine
the association between serum concentration of T3 with
components of MetS, CVR, and diet in euthyroid post-
menopausal women with and without MetS. An interest-
ing group to do this is the Otomi indigenous population
living in Ixtenco-Tlaxcala, México, in which a high preva-
lence of MetS components has been previously reported
(Cruz-Lumbreras et al. 2012).
Results
Correlation analyses between TSH or thyroid hormones
and cardio-metabolic variables were done in euthyroid
post-menopausal women. There was no correlation be-
tween the serum concentration of TSH and cardio-
metabolic variables. Total T4 was negatively correlated
with age but positively correlated with diastolic pressure.
Free T4 was positively correlated with glucose and dia-
stolic pressure. Total T3 was positively correlated with the
body mass index (BMI), the concentration of serum insu-
lin, and the insulin resistance index (HOMA-IR) but nega-
tively correlated with age, serum glucose, and high-density
lipoprotein cholesterol (HDL-C). Serum iodine concentra-
tion was negatively associated with TSH, but positively
correlated with free T4 and T3. Hormone concentrations
were not correlated with menarche, menopause age, or
the post-menopausal years (Table 1).
Due to the high correlation between T3 and cardio-
metabolic variables, women were grouped in: 1) women
without MetS (n = 33; without-MetS group), 2) women with
MetS and a low T3 concentration (quartile 1; n = 22; group
MetS-T3Q1); 3) women with MetS and a low-to-intermediate
T3 concentration (quartile 2; n = 21; group MetS-T3Q2); 4)
women with MetS and an intermediate-to-highT3 concentra-
tion (quartile 3; n = 21; group MetS-T3Q3); and 5) women
with MetS and a high T3 concentration (quartile 4; n = 23;
group MetS-T4Q4). The serum concentration of TSH was
similar between groups and the same was true for that of
free T4. The serum concentration of T4 for the MetS-T3Q1
group was significantly lower than that of MetS-T3Q3 and
MetS-T4Q4 groups. For its part, the concentration of T3
was low for the MetS-T3Q1 group and high for both MetS-
T3Q3 and MetS-T4Q4 groups (Table 2). As far as cardio-
metabolic variables are concerned, it was found that: a) age,
cholesterol, and blood pressure were similar between groups;
Table 1 Correlation analysis between TSH or thyroid
hormones and cardio-metabolic variables in euthyroid
post-menopausal women
Variable TSH T4 Free T4 T3
Age (years) -0.061 -0.205* -0.036 -0.205*
BMI (kg/m2) -0.108 0.114 0.136 0.220*
Glucose (mg/dL) -0.023 -0.010 0.261* -0.264**
Insulin (μUI/mL) -0.099 0.046 0.030 0.425***
HOMA-IR -0.079 0.080 0.167 0.239**
Triglycerides (mg/dL) 0.063 0.021 0.011 -0.052
Cholesterol (mg/dL) -0.045 -0.096 -0.022 -0.100
HDL-C (mg/dL) 0.113 0.034 0.084 -0.266**
Systolic pressure (mmHg) -0.038 0.067 0.136 -0.072
Diastolic pressure (mmHg) 0.125 0.201* 0.187* -0.002
Serum iodine (μg/L) -0.548*** 0.008 0.343* 0.286*
Menarche (years) -0.055 -0.004 -0.014 0.084
Age of menopause (years) 0.035 -0.109 -0.040 -0.157
Years post-menopause -0.021 -0.129 -0.010 -0.131
TSH, thyrotropin; T4, thyroxine; T3, triiodothyronine. BMI, body mass index;
HOMA-IR, insulin resistance; high-density lipoprotein cholesterol (HDL-C). All
participants (n = 120) were included for these analyses, except to the serum
iodine in which only samples from 52 women were measured. Simple Pearson
or Spearman correlation tests were applied. Values are correlation coefficients.
*P ≤ 0.05, **P < 0.01, and ***P < 0.001.
Table 2 Mean ± SD of thyrotropin (TSH), thyroid hormones, se
post-menopausal women grouped according to the presence
(T3) concentration
Without MetS MetS-T3Q1
n = 33 n = 22
TSH (μUI/mL) 2.8 ± 2.1a 2.5 ± 1.4a
T4 (μg/mL) 8.9 ± 0.4ab 8.2 ± 1.1b
Free T4 (μg/mL) 1.1 ± 0.2 1.1 ± 0.1
T3 (μg/mL) 1.2 ± 0.2ac 0.9 ± 0.1b
Range of T3 concentration (μg/mL) (0.81-1.47) (0.66-0.99)
Age (years) 67.4 ± 11.8 70.8 ± 8.6
BMI (kg/m2) 25.1 ± 5.3a 24.4 ± 3.8a
Glucose (mg/dL) 100.6 ± 30.6a 133.7 ± 47.5bc
Insulin (μUI/mL) 9.2 ± 5.8a 8.8 ± 8.6a
HOMA-IR 2.2 ± 1.4a 3.1 ± 3.4ab
HDL-C (mg/dL) 51.0 ± 19.3a 44.4 ± 9.6ab
Cholesterol (mg/dL) 198.5 ± 6.2 215.5 ± 13.6
Systolic pressure (mmHg) 118.2 ± 3.1a 125.5 ± 3.2ab
Diastolic pressure (mmHg) 73.6 ± 1.6 73.1 ± 1.5
T4, thyroxine; BMI, body mass index; HOMA-IR, insulin resistance index; high-density lip
Dunns post-hoc test were applied. Ns: no significant. Different letters indicate statistica
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found in groups with a high T3 concentration; and c) a
high glycaemia was present in groups with low or low-
intermediate T3 concentration (Table 2).
Comparing to women without and with MetS, binomial
logistic regression analyses showed that the risk to have
MetS components varies according to the T3 serum con-
centration. For waist circumference and HOMA-IR, the
odd ratio (OR) was high for MetS-T3 (Q2-Q4) groups,
while for the HDL-C the odd ratio was high for MetS-
T3Q3 and Q4 groups. The odd ratio to have an elevated
arterial tension and serum triglycerides was higher in
women with MetS that those without MetS, regardless of
T3 concentration. Women with MetS and a low concen-
tration of T3 had a high odd ratio for hyperglycemia and
CVR than those having a high T3 concentration (Table 3).
All groups had a low calorie intake that was accompan-
ied by a diminished intake of fiber, calcium, selenium, as-
corbic acid, vitamin E, and folate (Table 4). In highly
contrast, all women showed a high intake of iron (Table 4).
Both the intake of calories and iron were positively affected
by T3 concentration. Percentages for other dietetic alter-
ations were similar between groups (Table 4).
Discussion
In contrast to concentrations of TSH, total T4, and free
T4, the concentration of serum T3 was strongly correlated
with cardio-metabolic variables in postmenopausal Otomi
women. Although the concentration of T3 seems to berum iodine, and cardio-metabolic variables in euthyroid
of metabolic syndrome (MetS) and triiodothyronine
MetS-T3Q2 MetS-T3Q3 MetS-T3Q4 Statistic K
or F; Pn = 21 n =21 n = 23
2.3 ± 1.5a 2.6 ± 1.9a 2.4 ± 1.8a Ns
8.4 ± 1.5ab 9.7 ± 1.1a 9.4 ± 1.2a 4.0; 0.002
1.1 ± 0.1 1.1 ± 0.2 1.1 ± 0.1 Ns
1.1 ± 0.04a 1.2 ± 0.06c 1.4 ± 0.1d 62.9; <0.0001
(0.10-1.13) (1.14-1.33) (1.34-1.70)
68.9 ± 10.4 66.3 ± 7.5 64.9 ± 10.5 Ns
26.6 ± 3.5ab 26.8 ± 3.0ab 28.6 ± 5.0b 14.9; 0.004
158.0 ± 58.9c 135.5 ± 56.0bc 109.7 ± 57.5ab 28.5; <0.0001
10.0 ± 6.5a 12.6 ± 6.6ab 16.4 ± 7.0b 27.1; <0.0001
3.6 ± 1.8abc 4.3 ± 3.0bc 4.4 ± 2.0c 25.5; <0.0001
48.7 ± 30.0ab 40.1 ± 6.0b 39.7 ± 10.0ab 12.0; 0.01
197.9 ± 8.5 183.8 ± 9.3 195.6 ± 7.7 Ns
133.3 ± 3.9b 124.3 ± 2.9ab 129.6 ± 2.9ab 12.3; 0.01
73.3 ± 2.4 74.7 ± 2.4 75.7 ± 1.8 Ns
oprotein cholesterol (HDL-C). ANOVA or Kruskal-Wallis tests and Tukey-Kramer or
l differences between groups reported by post-hoc tests.
Table 3 Percentage and odds ratios (CI 95%) for metabolic syndrome (MetS) components and cardiovascular risk (CVR) in
euthyroid post-menopausal women grouped considering the presence of MetS and triiodothyronine (T3) concentration
Without MetS n=33 MetS-T3Q1 n=22 MetS-T3Q2 n=21 MetS-T3Q3 n=21 MetS-T3Q4 n=23
Waist circumference 30.3% 45.5% 66.7% 85.7% 82.6%
REF 2.8 (0.8-9.7) 6.4 (1.7-23.5)** 16.2 (3.6-72.8)*** 12.7 (3.0-53.3)***
Arterial tension 30.3% 72.7% 81.0% 61.9% 69.5%
REF 5.7 (1.6-19.2)** 10.0 (2.6-38.6)*** 4.1 (1.2-13.3)* 6.2 (1.8-21.0)**
Hyperglycemia 27.3% 95.5% 85.7% 66.7% 65.2%
REF 53.8 (6.2-462.2)*** 15.8 (3.7-67.4)*** 5.4 (1.6-18.1)** 5.2 (1.6-16.9)**
Triglycerides 24.2% 72.7% 52.4% 57.1% 65.2%
REF 8.0 (2.3-27.8)** 3.3 (1.0-10.9)* 4.2 (1.3-13.7)* 6.0 (1.8-19.6)**
Low HDL-C 54.5% 76.2%(21) 76.2% 95.2% 85.7% (21)
REF 2.8 (0.8-9.5) 2.7 (0.8-9.2) 16.4 (1.9-137.6)* 4.9 (1.2-20.0)*
HOMA-IR 24.2% 36.3% 66.7% 66.7% 78.2%
REF 2.4 (0.6-8.5) 8.3 (2.2-30.5)*** 6.8 (1.9-24.2)** 12.3 (3.2-47.1)***
CVR moderate/high 6.1% 45.5%(21) 52.4% 47.6% 19.0%(21)
REF 14.6 (2.7-78.6)*** 17.4 (3.2-92.9)*** 14.0 (2.6-74.3)** 3.5 (0.5-21.7)
Binomial logistic regression was applied adjusting age was for all cases. HDL-C, HDL cholesterol; HOMA-IR, insulin resistance. *P ≤ 0.05, **P < 0.01, and ***P < 0.001.
Note: HDL-C was not possible to be measure for all women. Numbers into superscript parenthesis together to prevalence for groups MetS-T3Q1 and MetS-T3Q4
indicate the number of participants for HDL-C and CVR.
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varies in line with quartiles of the normal-concentration of
this hormone. Low-normal values of T3 are related to the
presence of a high glucose concentration and a moderate-
high CVR. Meanwhile, high-normal values of T3 are asso-
ciated with a high insulin level, HOMA-IR, a high BMI,
and low HDL-C. Triglycerides and arterial pressures did
not have a clear relation with the serum concentration of
T3. The analysis of diet composition showed an evident
malnutrition. Most women enrolled in this study ingest a
low content of calories, lipids, minerals, and vitamins. The
quality of the diet was not correlated with the presence of
MetS, albeit women having a high-normal concentration
of T3 consume more calories and iron, which was not
enough to improve the extent of malnutrition.
There is much information about the relation between
T4 or TSH and cardio-metabolic variables (De Pergola
et al. 2010; Lambadiari et al. 2011; Taneichi et al. 2011;
Tarcin et al. 2012), but only a few studies have been done
in old people, and particularly in post-menopausal women
(Park et al. 2009; Takamura et al. 2009; Topsakal et al.
2012). In agreement with our results, a high T3 (total or
free) concentration has been associated with a high BMI
(De Pergola et al. 2010; Taneichi et al. 2011; Tarcin et al.
2012; Roef et al. 2014), which may be related to the pro-
motion of adipocyte differentiation (Flores-Delgado et al.
1987). Triiodotironine also shows a positive association
with insulin resistance (Lambadiari et al. 2011; Tarcin
et al. 2012) but a negative association with hyperglycemia
(Taneichi et al. 2011). This fact could be explained be-
cause the T3 affects the absorption of glucose in thegastrointestinal tract, the liberation of glucose by hep-
atic tissue, cellular glucose transport, insulin secretion
by pancreas, and the glucose utilization by muscle cells
(Wang 2013).
Our present results about the positive correlation be-
tween T3 and CVR agree with other studies reporting that
low T3 levels are present in old women/men with heart
failure, coronary artery disease, atherosclerosis, myocardial
infarction or cardiomyopathies (Selvaraj et al. 2012; Yang
et al. 2012). In contrast, the HDL-C is negatively affected
by serum T3 levels although this could not ameliorate the
positive actions of T3 on vascular function (Takamura
et al. 2009; De Pergola et al. 2010; Chin et al. 2014; Roef
et al. 2014). These actions of T3 on the vascular smooth
muscle relaxation are well known (Ojamaa et al. 1993), as
well as its negative relation with pro-inflammatory mole-
cules (Lubrano et al. 2010).
In the present study, women had a low intake of calo-
ries, and an important deficiency of minerals and vitamins.
Such malnutrition could be associated with the ageing an-
orexia and loss of dentition (Kmieć et al. 2013) as well as
to the extent of poverty present in indigenous communi-
ties (Gracey and King 2009). This finding is important due
to the relevance of an adequate nutrition in old people to
avoid cardiovascular and metabolic diseases (Da Silva and
Rudkowska 2014). In this regard, we previously found a
high prevalence of overweight, obesity, type two diabetes
mellitus (T2DM), hypertriglyceridemia, and MetS in old
Otomi women (Cruz-Lumbreras et al. 2012). Given the
present results is tentative to speculate that the latter
metabolic alterations are associated with the malnutrition
Table 4 Means ± SD of dietetic variables, percentage of dietetic deficiencies, and odds ratio (OR) of dietetic alterations













F; P; χ2; P
Caloric intake (kcal/day) 1401.1 ± 514.3 1217.8 ± 380.1 1301.2 ± 500.3 1310.4 ±300.1 1584.7 ± 598.7 Ns
Low calories intake <1600 Kcal/day 69%a 95%b 68.8%ab 83.3%ab 52.6%a 10.3; 0.03
OR (CI 95%) for low calories intake
without age adjusted
REF 8.5 (0.9-74.0)* 0.9 (0.2-3.6) 2.2 (0.5-9.7) 0.5 (0.1-1.6)
OR (CI 95%) for low calories intakeǂ REF 7.3 (0.8-65.8)┼ 1.0 (0.2-4.0) 2.3 (0.5-10.6) 0.5 (0.1-2.0)
Protein intake (g/day) 50.8 ± 20.4 46.8 ± 16.0 51.7 ± 19.7 49.4 ± 16.6 63.7 ± 28.7 Ns
Low protein intake (range 10-35%) 6.9% 5% 12.5% 5.5% 0.0% Ns
OR (CI 95%) for low protein intakeǂ REF 0.6 (0.05-7.9) 1.9 (0.2-16.1) 0.7 (0.6-9.7) NA
Lipid intake (g/day) 36.31 ± 24.9 31.6 ± 17.9 30.4 ± 15.8 34.8 ± 15.6 42.6 ± 27.7 Ns
Low lipid intake (range 20-35%) 48.3% 35.0% 43.8% 22.2% 31.5% Ns
OR (CI 95%) for low lipid intakeǂ REF 0.5 (0.1-1.8) 1.0 (0.2-3.6) 0.3 (0.09-1.4) 0.8 (0.2-3.1)
Carbohydrate intake (g/day) 218.4 ± 71.5 186.6 ± 64.1 205.3 ± 101.5 200.4 ± 49.6 236.7 ± 74.4 Ns
High carbohydrate intake (range 45-65%) 44.8% 25.0% 25.0% 22.2% 26.3% Ns
OR (CI 95%) for high carbohydrate intakeǂ REF 0.4 (0.1-1.4) 0.4 (0.1-1.8) 0.4 (0.1-1.5) 0.6 (0.1-2.4)
Fiber (g/day) 15.2 ± 5.6 14.2 ± 6.6 15.0 ± 4.2 14.5 ± 3.3 18.7 ± 5.9 6 Ns
Low fiber intake <22 g/day 86.2% 85.0% 93.8% 100% 8.4% Ns
Calcium (mg/day) 991.2 ± 443.9 909.8 ± 333.0 1071.5 ± 488.1 909.9 ± 326.1 1227.6 ± 589.9 Ns
Low calcium intake <1200 mg/day 69.0% 80.0% 68.8% 88.9% 52.6% Ns
Sodium (mg/day) 1418.5 ± 581.6 1333.1 ± 577.8 1379.8 ± 411.3 1405.5 ± 328.9 1735.4 ± 578.5 Ns
High sodium intake <2300 mg/day 10.3% 10.0% 6.3% 0.0% 15.7% Ns
Phosphorous (mg/day) 761.3 ± 301.1 680.7 ± 217.0 810.2 ± 432.7 737.4 ± 229.8 885.9 ± 329.4 Ns
Low phosphorous intake <700 mg/day 48.3% 65.0% 37.5% 50.0% 36.0% Ns
Iron (mg/day) 31.2 ± 10.3ab 28.6 ± 12.2a 31.1 ± 8.4ab 29.3 ± 6.3 ab 38.3 ± 12.5b 2.6; 0.03
Low iron intake <8 mg/day 0.0% 0.0% 0.0% 0.0% 0.0% Ns
Selenium (mg/day) 25.8 ± 23.7 25.2 ± 20.6 33.3 ± 24.3 25.7 ± 19.9 37.6 ± 25.1 Ns
Low selenium intake <55 mg/day 82.8% 95.0% 75.0% 83.3% 63.1% Ns
Ascorbic acid (mg/day) 30.1 ± 31.7 46.1 ± 72.3 35.2 ± 28.5 28.0 ± 33.5 29.6 ± 13.8 Ns
Low ascorbic acid intake <75 mg/day 89.7% 90.0% 93.8% 94.4% 100.0% Ns
Vitamin A (μg ER/day) 621.8 ± 476.1 615.7 ± 338.4 752.8 ± 462.2 605.8 ± 324.2 768.4 ± 352.9 Ns
Low vitamin A intake <700 mg/day 62.1% 65.0% 50.0% 61.1% 47.3% Ns
Vitamin E (mg/day) 4.2 ± 3.3 6.3 ± 4.5 4.9 ± 2.5 6.0 ± 3.9 5.6 ± 3.1 Ns
Low vitamin E intake <15 mg/day 100.0% 95.0% 100.0% 100.0% 100.0% Ns
Folate (mcg/day) 71.0 ± 76.1 91.0 ± 88.1 66.3 ± 68.8 67.0 ± 79.6 70.5 ± 32.9 Ns
Low folate intake <400 mcg/day 100.0% 100.0% 100.0% 100.0% 100.0% Ns
Note: Diet survey was applied to 102 women. ANOVA or Kruskal-Wallis tests and Tukey-Kramer or Dunn’s post-hoc tests, and chi-square were applied. ǂBinomial
regression analysis (age and BMI adjusted) were done for macronutrients. Ns: no significant. Different letters indicate statistical differences between groups
reported by post-hoc tests. *P = 0.05; ┼P = 0.07.
Luna-Vazquez et al. SpringerPlus 2014, 3:266 Page 5 of 8
http://www.springerplus.com/content/3/1/266reported in the present study. However, our results could
not be compared to other studies because the lack of
information about nutrition of older indigenous from
México. Some studies have shown that Tarahumara chil-
dren have a deficient ingest of iodine, zinc, vitamin B12,
iron, and folate (Monárrez-Espino et al. 2004; Monárrez-
Espino and Greiner 2005), which suggests a similarcondition for old people. A particular mention should be
done about iron intake in Otomi women, because most of
the intake of this mineral corresponds to non-heme iron
(from leguminous plants) that is absorbed in less extent
(MacPhail 2001).
Although the type of diet was similar between groups,
there was a positive association between the serum
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that could be associated with a high body weight and
intake of iron. These results agree with other studies
(Serog et al. 1982; Roti et al. 2000) and may be linked to
the promotion of appetite by T3 (Emami et al. 2014). How-
ever, a high-normal concentration of T3 was not able to re-
lieve the anorexia and the consequent weight loss at ageing
(Kmieć et al. 2013). The latter could occur also for mineral
and vitamin deficiencies possibly due to the bad quality of
the diet ingested by this indigenous group. In this way, a
nutritional intervention on the old population could be
necessary to avoid cardio-metabolic alterations and to in-
crease thyroid hormones concentrations. It is known that a
dietary imbalance is related to MetS (Al-Daghri et al. 2013),
and the supplementation of vitamin A increases the serum
T3 concentration (Farhangi et al. 2012).
Conclusions
In contrast to serum concentrations of TSH, total T4,
and free T4, the concentration of serum T3 was strongly
correlated with cardio-metabolic variables in euthyroid
postmenopausal women. In comparison to women without
MetS, a high-normal serum concentration of T3 in women
with MetS is positively associated with reduced glycaemia
and CVR but negatively related to BMI, insulin, HOMA-
IR, and HDL-C. Although the analyzed population had
nutritional deficiency, both the intake of calories and iron
were positively affected by the T3 concentration. Our re-
sults suggest the necessity that health programs monitoring
T3 in old people in order to treat hyperglycemia, cardio-
metabolic components, and the ageing anorexia.
Methods
This was a cross-sectional study in volunteer post-
menopausal indigenous women from Ixtenco-Tlaxcala,
México. Post-menopause was defined as the lack of the
menstrual period occurring naturally for at least three
years (Heidari et al. 2010). Participants were recruited
through personal invitations that were done by the local
Health Office from Ixtenco-Tlaxcala. Women were physic-
ally active, could skillfully walk, and most of them were
farmer. The criterion to be considered as euthyroid women
was to have a concentration of TSH <10 μUI/mL (Benseñor
et al. 2012). Women with chronic liver or renal diseases,
cancer, neurological or psychological illness (depression,
epilepsy, and schizophrenia), thyroidectomy, and those
being under treatment with estrogen, androgen, or lithium
medication were excluded. This study was done in accord-
ance with the Helsinki Declaration of Human Studies and
was approved by Ethical Committees of the Health Office
from the State of Tlaxcala and the Universidad Autónoma
de Tlaxcala. All participants provided a written inform con-
sent. Anthropometric and clinical measurements were ob-
tained by specialized personnel. Menarche and menopauseage were also recorded. Thus, 120 women having more
than 45 years old (corresponding to 13.5% of eligible popu-
lation from Ixtenco, Tlaxcala) were included in this study.Metabolic syndrome determination
Metabolic syndrome was diagnosed using the American
Heart Association/National Heart, Lung, and Blood Institute
Scientific Statement (AHA/NHLBI) (Guize et al. 2008) criter-
ion that considers: a) abdominal obesity, defined as a waist
circumference ≥88 cm; b) serum triglycerides ≥150 mg/dL
or to be under current medication for dyslipidemias; c)
HDL-C <50 mg/dL; d) blood pressure ≥130/85 mmHg
or to be under current use of antihypertensive medication;
and e) fasting plasma glucose ≥100 mg/dL or to be under
current use of hypoglycemic medication. Serum concentra-
tion of glucose, total cholesterol and triglycerides were mea-
sured using standard enzymatic methods (ELITech, France).
The HDL-C was measured using a precipitating method
(ELITech, France). Blood pressures monitor (Homecare,
México) and stethoscope (Medimetrics, México) were used
to measure both systolic and diastolic pressures. The BMI
was calculated as weight (kg) divided by the square of height
(m2) and was used as an index of overall adiposity. Due to
elderly subjects commonly are shorter and slimmer than
their younger counterparts, the height was estimated by the
half arm span (Shahar and Pooy 2003).Hormone measurements
Blood samples were obtained from ante-cubital veins of
participants having a fast of 12 h. Serum was allowed to clot
and then separated by centrifugation and stored at −20°C.
Serum concentration of TSH, total T4, free T4, total T3,
and estradiol were measured using a chemiluminescence
method that was carried out by CARPERMOR Laborator-
ies, S.A. de C.V. Manufacturers were blinded to the thyroid
history of participants and to any other data from them.
Serum concentration of insulin was also measured by
chemiluminescence, and insulin resistance was calculated
using the HOMA-IR [fasting insulin (μU/mL) x fasting
serum glucose (mg/dL)/405], using a cutoff ≥ 2.7 (Topsakal
et al. 2012).Serum iodine measurement
Serum iodine was measured using a method based on
the Sandell–Kolthoff reaction. Briefly, serum proteins
were precipitate and afterwards incinerated in an alkaline
medium. Iodine was determined by the rate of color disap-
peared at 504 nm. Iodine bound to protein was reported
as μg/L. Sensibility of the assay was 0.005 μg/L. A concen-
tration of serum iodine ranging from 50 to 100 μg/L was
considered as normal (Risher and Keith 2009).
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The CVR was determined using the Framingham scale
that considers risk factors such as age, sex, lipids, systolic
blood pressure, smoking habits, and glucose levels (Wilson
et al. 1998). According to the Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus (2003),
the T2DM was diagnosed when a fasting glucose concen-
tration ≥ 126 mg/dL was measured or when participants
had been previously diagnosed. Hypertension was diag-
nosed when the systolic pressure was ≥ 140 mmHg; the
diastolic pressure was ≥ 90 mmHg or when women had a
current use of anti-hypertensive medication (Wilson et al.
1998). A moderate risk was considered for 15-20% of
score, and a high risk was >20%.
Diet analysis
Dietary information was collected by the 24-hours recall
method, applying personal interviews from Tuesday to
Friday at participant’s address. Carbohydrate, protein,
lipid, vitamins, and minerals intake were calculated using
the Mexican Food Equivalent System (Perez-Lizaur et al.
2008) and Dietary Guidelines for Americans (2010). Total
intake calories were compared with resting metabolic rate
estimated by Harris-Benedict formula (Melzer et al. 2007).
Nutrient recommendations were based on the Dietary
Guidelines for Americans (2010).
Statistical analysis
Data were analyzed using the Statistical Package for the
Social Sciences software version 17. Correlation analyses
involving thyroid hormones or TSH and cardio-vascular
variables from all participants (unless otherwise is men-
tioned) were carried out using Pearson or Spearman ana-
lyses. To analyze the association of normal-concentration
of T3 with cardio-metabolic and dietetic variables, women
were allocated in five groups. The control group was con-
stituted by women without MetS, the rest of groups were
women with MetS organized by quartiles to T3 (MetS-
T3Q1 to MetS-T3Q4). Statistical comparisons between
variables were done using Kruskal Wallis, ANOVA ana-
lyses, or chi-square tests as it was necessary. Binary logistic
regression analysis was used to determine the risk to
present any cardio-metabolic (adjusting age) or macro-
nutritional alterations (adjusting age and BMI) between
groups. Data are expressed as mean ± standard deviation
(SD), prevalence (%), or OR and 95% confidence intervals
(CI). A statistical significance was considered at a P ≤ 0.05.
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